Mergers & Acquisitions - Pharmaceutical, Research

Filter

Current filters:

PharmaceuticalResearch

Popular Filters

1 to 25 of 42 results

KCR acquires project portfolio from Ukraine’s CRO AXIS

KCR acquires project portfolio from Ukraine’s CRO AXIS

17-12-2014

KCR, a Poland-based contract research organization (CRO), has recently acquired the whole portfolio of…

AXIS GroupKCRMergers & AcquisitionsPharmaceuticalResearchUkraine

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

Ricerca Biosciences sells out to equity investment group

19-11-2014

After conducting a thorough process to evaluate strategic acquisition offers for the company, the Ricerca…

Mergers & AcquisitionsPharmaceuticalResearchRicerca Biosciences

Roche partners in new company for MS research

Roche partners in new company for MS research

23-06-2014

Swiss drug major Roche has entered into an exclusive partnership with Inception Sciences, a drug discovery…

Inception 5Inception SciencesMergers & AcquisitionsNeurologicalPharmaceuticalResearchRocheVersant Ventures

AstraZeneca stresses confidence in independence, highlighting strong R&D pipeline

15-05-2014

Anglo-Swedish pharma major AstraZeneca, the subject of the controversial takeover attempt by Pfizer,…

AstraZenecaCardio-vascularMergers & AcquisitionsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

06-05-2014

In a bid to explain its rejection of US pharma giant Pfizer’s increased takeover bid for the Anglo-Swedish…

AstraZenecaFinancialMergers & AcquisitionsPfizerPharmaceuticalResearch

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

06-05-2014

Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

Perrigo transfers ELND005 assets; buys OTC products

01-03-2014

Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder

Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder

17-02-2014

Privately-held USA-based Prothelia and the University of Nevada, Reno, have entered into strategic agreements…

Alexion PharmaceuticalsMergers & AcquisitionsPharmaceuticalProtheliaRare diseasesResearch

Moderna spins-out Onkaido Therapeutics to focus on mRNA therapeutics in oncology

15-01-2014

Flush with cash as a result of its mega-million dollar deal with Alexion on the development of drugs…

Mergers & AcquisitionsModerna TherapeuticsOncologyOnkaido TherapeuticsPharmaceuticalResearch

NeXeption forms new company, Alexar Therapeutics, to develop novel LXR agonist portfolio

03-01-2014

US biopharma management company NeXeption says it has secured $21.5 million in Series A financing to…

A-110Alexar TherapeuticsDermatologicalsFinancialMergers & AcquisitionsNeXeptionPharmaceuticalResearch

Astellas links with Mitokyne on mitochondria-related therapies

Astellas links with Mitokyne on mitochondria-related therapies

07-10-2013

Japanese drug major Astellas Pharma and USA-based start-up Mitokyne have entered into an exclusive R&D…

Astellas PharmaFinancialLicensingMergers & AcquisitionsMitokynePharmaceuticalResearch

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?

03-06-2013

US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Briefs: Royalty sweetens offer for Elan; AstraZeneca biomarker deal

16-04-2013

US private equity company Royalty Pharma today (April 15) issued a firm improved takeover offer for Ireland-based…

AstraZenecaElanLicensingMergers & AcquisitionsOncologyOxford Cancer BiomarkersPharmaceuticalResearchRoyalty Pharma

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X

03-04-2013

In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Phytopharm views options, including merger, as Cogane fails

27-03-2013

UK-based Phytopharm (LSE: PYM: London Stock Exchange), ahead of its annual general meeting today (March…

CoganeMergers & AcquisitionsNeurologicalPharmaceuticalPhytopharmResearch

Sorrento Therapeutics signs exclusive option to acquire IGDRASOL

08-03-2013

USA-based Sorrento Therapeutics, Inc. (SRNE: OB) has signed an exclusive option to acquire IGDRASOL,…

IGDRASOLMergers & AcquisitionsOncologyPharmaceuticalResearchSorrento Therapeutics

GlaxoSmithKline and Biological E set up JV to develop combination vaccine

29-01-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into…

Asia-PacificBiological E LtdGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResearchVaccines

DelMar Pharma acquisition; $5.4 million private placement to advance novel cancer therapies

28-01-2013

DelMar Pharmaceuticals (OTCQB: BRRY) has announced the successful acquisition, through a share exchange…

DelMar PharmaceuticalsFinancialMergers & AcquisitionsOncologyPharmaceuticalResearchVAL-083

Teijin collaborates with InCube Labs to boost health care business

22-01-2013

Japan's Teijin (TYO: 3401) says it has signed a strategic partnership agreement with InCube Labs, a California-based…

InCube LabsMergers & AcquisitionsPharmaceuticalResearchTeijin

Illumina to buy Verinata; Rusnano et al invest in Marinus

08-01-2013

USA-based Illumina (Nasdaq: ILMN), recently the subject of a failed takeover bid by Swiss drug major…

Domain AssociatesFinancialganaxoloneIlluminaMarinus PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalResearchRusNanoVerinata Health

Japan Pharma: Expectations for 2013, by P Reed Maurer

03-01-2013

The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

1 to 25 of 42 results

Back to top